Review



viogreen labeled cd8a  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Miltenyi Biotec viogreen labeled cd8a
    Parotid glands were prepared as described in . A) Viable CD3+ T cells. B) Viable CD3- cells. C) Viable CD49b+ NK cells. D) Viable CD4+ T cells. E) Viable <t>CD8+</t> T cells. F) Viable CD4+CD8+ double positive T cells. G) Viable CD4-CD8- double negative T cells. Data analyzed by one-way ANOVA with Tukey’s post-hoc test and represented as mean ± SEM. Treatment groups with the same letter are not statistically different from each other.
    Viogreen Labeled Cd8a, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/viogreen+labeled+cd8a/CD8a+Antibody%2C+anti-rat%2C+VioGreen+%2C+REAfinity/pmc10931461-53-29-37
    Average 93 stars, based on 7 article reviews
    viogreen labeled cd8a - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "Parotid glands have a dysregulated immune response following radiation therapy"

    Article Title: Parotid glands have a dysregulated immune response following radiation therapy

    Journal: PLOS ONE

    doi: 10.1371/journal.pone.0297387

    Parotid glands were prepared as described in . A) Viable CD3+ T cells. B) Viable CD3- cells. C) Viable CD49b+ NK cells. D) Viable CD4+ T cells. E) Viable CD8+ T cells. F) Viable CD4+CD8+ double positive T cells. G) Viable CD4-CD8- double negative T cells. Data analyzed by one-way ANOVA with Tukey’s post-hoc test and represented as mean ± SEM. Treatment groups with the same letter are not statistically different from each other.
    Figure Legend Snippet: Parotid glands were prepared as described in . A) Viable CD3+ T cells. B) Viable CD3- cells. C) Viable CD49b+ NK cells. D) Viable CD4+ T cells. E) Viable CD8+ T cells. F) Viable CD4+CD8+ double positive T cells. G) Viable CD4-CD8- double negative T cells. Data analyzed by one-way ANOVA with Tukey’s post-hoc test and represented as mean ± SEM. Treatment groups with the same letter are not statistically different from each other.

    Techniques Used:

    For analysis at day 5, IGF-1 was injected via tail vein at day 4 post IR, and parotid tissue was harvested 24 hours later. For analysis at day 30, IGF-1 was injected via tail vein at days 4, 5, and 6 following IR, and parotid tissue was dissected at day 30 post IR. A) Viable CD3+ T cells. B) Viable CD3- cells C) Viable CD49b+ NK cells. D) Viable CD4+ T cells. E) Viable CD8+ T cells. F) Viable CD4+CD8+ double positive T cells. G) Viable CD4-CD8- double negative T cells. Data analyzed by one-way ANOVA with Tukey’s post-hoc test and represented as mean ± SEM. Treatment groups with the same letter are not statistically different from each other.
    Figure Legend Snippet: For analysis at day 5, IGF-1 was injected via tail vein at day 4 post IR, and parotid tissue was harvested 24 hours later. For analysis at day 30, IGF-1 was injected via tail vein at days 4, 5, and 6 following IR, and parotid tissue was dissected at day 30 post IR. A) Viable CD3+ T cells. B) Viable CD3- cells C) Viable CD49b+ NK cells. D) Viable CD4+ T cells. E) Viable CD8+ T cells. F) Viable CD4+CD8+ double positive T cells. G) Viable CD4-CD8- double negative T cells. Data analyzed by one-way ANOVA with Tukey’s post-hoc test and represented as mean ± SEM. Treatment groups with the same letter are not statistically different from each other.

    Techniques Used: Injection

    Related Articles

    Immunofluorescence:

    Article Title: Parotid glands have a dysregulated immune response following radiation therapy
    Article Snippet: .. An eight-color direct immunofluorescence protocol was used to label digested murine salivary glands with the following monoclonal antibodies: VioBlue-labeled Ly-6G, VioGreen-labeled CD11b, APC-labeled F4/80, APC-Vio 770-labeled CD45, VioBlue-labeled CD4, VioGreen-labeled CD8a, FITC-labeled CD3, and PE-Vio 770-labeled CD49b (Miltenyi Biotec, Auburn, CA) and analyzed by flow cytometry (Miltenyi Biotec MacsQuant, Auburn, CA). ..

    Bioprocessing:

    Article Title: Parotid glands have a dysregulated immune response following radiation therapy
    Article Snippet: .. An eight-color direct immunofluorescence protocol was used to label digested murine salivary glands with the following monoclonal antibodies: VioBlue-labeled Ly-6G, VioGreen-labeled CD11b, APC-labeled F4/80, APC-Vio 770-labeled CD45, VioBlue-labeled CD4, VioGreen-labeled CD8a, FITC-labeled CD3, and PE-Vio 770-labeled CD49b (Miltenyi Biotec, Auburn, CA) and analyzed by flow cytometry (Miltenyi Biotec MacsQuant, Auburn, CA). ..

    Flow Cytometry:

    Article Title: Parotid glands have a dysregulated immune response following radiation therapy
    Article Snippet: .. An eight-color direct immunofluorescence protocol was used to label digested murine salivary glands with the following monoclonal antibodies: VioBlue-labeled Ly-6G, VioGreen-labeled CD11b, APC-labeled F4/80, APC-Vio 770-labeled CD45, VioBlue-labeled CD4, VioGreen-labeled CD8a, FITC-labeled CD3, and PE-Vio 770-labeled CD49b (Miltenyi Biotec, Auburn, CA) and analyzed by flow cytometry (Miltenyi Biotec MacsQuant, Auburn, CA). ..



    Similar Products

    viogreen labeled cd8a  (Miltenyi Biotec)
    93
    Miltenyi Biotec viogreen labeled cd8a
    Parotid glands were prepared as described in . A) Viable CD3+ T cells. B) Viable CD3- cells. C) Viable CD49b+ NK cells. D) Viable CD4+ T cells. E) Viable <t>CD8+</t> T cells. F) Viable CD4+CD8+ double positive T cells. G) Viable CD4-CD8- double negative T cells. Data analyzed by one-way ANOVA with Tukey’s post-hoc test and represented as mean ± SEM. Treatment groups with the same letter are not statistically different from each other.
    Viogreen Labeled Cd8a, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/viogreen+labeled+cd8a/CD8a+Antibody%2C+anti-rat%2C+VioGreen+%2C+REAfinity/pmc10931461-53-29-37
    Average 93 stars, based on 1 article reviews
    viogreen labeled cd8a - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Parotid glands were prepared as described in . A) Viable CD3+ T cells. B) Viable CD3- cells. C) Viable CD49b+ NK cells. D) Viable CD4+ T cells. E) Viable CD8+ T cells. F) Viable CD4+CD8+ double positive T cells. G) Viable CD4-CD8- double negative T cells. Data analyzed by one-way ANOVA with Tukey’s post-hoc test and represented as mean ± SEM. Treatment groups with the same letter are not statistically different from each other.

    Journal: PLOS ONE

    Article Title: Parotid glands have a dysregulated immune response following radiation therapy

    doi: 10.1371/journal.pone.0297387

    Figure Lengend Snippet: Parotid glands were prepared as described in . A) Viable CD3+ T cells. B) Viable CD3- cells. C) Viable CD49b+ NK cells. D) Viable CD4+ T cells. E) Viable CD8+ T cells. F) Viable CD4+CD8+ double positive T cells. G) Viable CD4-CD8- double negative T cells. Data analyzed by one-way ANOVA with Tukey’s post-hoc test and represented as mean ± SEM. Treatment groups with the same letter are not statistically different from each other.

    Article Snippet: An eight-color direct immunofluorescence protocol was used to label digested murine salivary glands with the following monoclonal antibodies: VioBlue-labeled Ly-6G, VioGreen-labeled CD11b, APC-labeled F4/80, APC-Vio 770-labeled CD45, VioBlue-labeled CD4, VioGreen-labeled CD8a, FITC-labeled CD3, and PE-Vio 770-labeled CD49b (Miltenyi Biotec, Auburn, CA) and analyzed by flow cytometry (Miltenyi Biotec MacsQuant, Auburn, CA).

    Techniques:

    For analysis at day 5, IGF-1 was injected via tail vein at day 4 post IR, and parotid tissue was harvested 24 hours later. For analysis at day 30, IGF-1 was injected via tail vein at days 4, 5, and 6 following IR, and parotid tissue was dissected at day 30 post IR. A) Viable CD3+ T cells. B) Viable CD3- cells C) Viable CD49b+ NK cells. D) Viable CD4+ T cells. E) Viable CD8+ T cells. F) Viable CD4+CD8+ double positive T cells. G) Viable CD4-CD8- double negative T cells. Data analyzed by one-way ANOVA with Tukey’s post-hoc test and represented as mean ± SEM. Treatment groups with the same letter are not statistically different from each other.

    Journal: PLOS ONE

    Article Title: Parotid glands have a dysregulated immune response following radiation therapy

    doi: 10.1371/journal.pone.0297387

    Figure Lengend Snippet: For analysis at day 5, IGF-1 was injected via tail vein at day 4 post IR, and parotid tissue was harvested 24 hours later. For analysis at day 30, IGF-1 was injected via tail vein at days 4, 5, and 6 following IR, and parotid tissue was dissected at day 30 post IR. A) Viable CD3+ T cells. B) Viable CD3- cells C) Viable CD49b+ NK cells. D) Viable CD4+ T cells. E) Viable CD8+ T cells. F) Viable CD4+CD8+ double positive T cells. G) Viable CD4-CD8- double negative T cells. Data analyzed by one-way ANOVA with Tukey’s post-hoc test and represented as mean ± SEM. Treatment groups with the same letter are not statistically different from each other.

    Article Snippet: An eight-color direct immunofluorescence protocol was used to label digested murine salivary glands with the following monoclonal antibodies: VioBlue-labeled Ly-6G, VioGreen-labeled CD11b, APC-labeled F4/80, APC-Vio 770-labeled CD45, VioBlue-labeled CD4, VioGreen-labeled CD8a, FITC-labeled CD3, and PE-Vio 770-labeled CD49b (Miltenyi Biotec, Auburn, CA) and analyzed by flow cytometry (Miltenyi Biotec MacsQuant, Auburn, CA).

    Techniques: Injection